Patterns of Diagnostic Imaging and Associated Radiation Exposure Among Long-term Survivors of Young Adult Cancer: a Population-based Cohort Study
Overview
Authors
Affiliations
Background: Survivors of young adult malignancies are at risk of accumulated exposures to radiation from repetitive diagnostic imaging. We designed a population-based cohort study to describe patterns of diagnostic imaging and cumulative diagnostic radiation exposure among survivors of young adult cancer during a survivorship time period where surveillance imaging is not typically warranted.
Methods: Young adults aged 20-44 diagnosed with invasive malignancy in Ontario from 1992-1999 who lived at least 5 years from diagnosis were identified using the Ontario Cancer Registry and matched 5 to 1 to randomly selected cancer-free persons. We determined receipt of 5 modalities of diagnostic imaging and associated radiation dose received by survivors and controls from years 5-15 after diagnosis or matched referent date through administrative data. Matched pairs were censored six months prior to evidence of recurrence.
Results: 20,911 survivors and 104,524 controls had a median of 13.5 years observation. Survivors received all modalities of diagnostic imaging at significantly higher rates than controls. Survivors received CT at a 3.49-fold higher rate (95% Confidence Interval [CI]:3.37, 3.62) than controls in years 5 to 15 after diagnosis. Survivors received a mean radiation dose of 26 miliSieverts solely from diagnostic imaging in the same time period, a 4.57-fold higher dose than matched controls (95% CI: 4.39, 4.81).
Conclusions: Long-term survivors of young adult cancer have a markedly higher rate of diagnostic imaging over time than matched controls, imaging associated with substantial radiation exposure, during a time period when surveillance is not routinely recommended.
Baltz A, Siegel E, Kamal A, Siegel R, Kozlik M, Crist S JCO Oncol Pract. 2022; 19(2):e274-e285.
PMID: 36375114 PMC: 9970287. DOI: 10.1200/OP.22.00500.
Mullen E, Chi Y, Hibbitts E, Anderson J, Steacy K, Geller J J Clin Oncol. 2018; :JCO1800076.
PMID: 30335557 PMC: 6269130. DOI: 10.1200/JCO.18.00076.
Hay J, Baser R, Westerman J, Ford J Int J Behav Med. 2018; 25(5):569-578.
PMID: 29872990 PMC: 6281846. DOI: 10.1007/s12529-018-9730-3.
Factors associated with imaging in patients with early breast cancer after initial treatment.
Enright K, Desai T, Sutradhar R, Gonzalez A, Powis M, Taback N Curr Oncol. 2018; 25(2):126-132.
PMID: 29719428 PMC: 5927783. DOI: 10.3747/co.25.3838.
Acuna S, Sutradhar R, Kim S, Baxter N Transplantation. 2018; 102(7):1156-1164.
PMID: 29557910 PMC: 7228636. DOI: 10.1097/TP.0000000000002178.